Fox Richard J, Davis S Christopher, Mundorff Emily C, Newman Lisa M, Gavrilovic Vesna, Ma Steven K, Chung Loleta M, Ching Charlene, Tam Sarena, Muley Sheela, Grate John, Gruber John, Whitman John C, Sheldon Roger A, Huisman Gjalt W
Codexis, Inc., 200 Penobscot Drive, Redwood City, California 94063, USA.
Nat Biotechnol. 2007 Mar;25(3):338-44. doi: 10.1038/nbt1286. Epub 2007 Feb 18.
We describe a directed evolution approach that should find broad application in generating enzymes that meet predefined process-design criteria. It augments recombination-based directed evolution by incorporating a strategy for statistical analysis of protein sequence activity relationships (ProSAR). This combination facilitates mutation-oriented enzyme optimization by permitting the capture of additional information contained in the sequence-activity data. The method thus enables identification of beneficial mutations even in variants with reduced function. We use this hybrid approach to evolve a bacterial halohydrin dehalogenase that improves the volumetric productivity of a cyanation process approximately 4,000-fold. This improvement was required to meet the practical design criteria for a commercially relevant biocatalytic process involved in the synthesis of a cholesterol-lowering drug, atorvastatin (Lipitor), and was obtained by variants that had at least 35 mutations.
我们描述了一种定向进化方法,该方法在生成符合预定义工艺设计标准的酶方面应具有广泛的应用。它通过纳入一种蛋白质序列活性关系(ProSAR)统计分析策略,增强了基于重组的定向进化。这种结合通过允许捕获序列活性数据中包含的额外信息,促进了以突变为导向的酶优化。因此,该方法即使在功能降低的变体中也能识别出有益突变。我们使用这种混合方法来进化一种细菌卤代醇脱卤酶,该酶将氰化过程的体积生产率提高了约4000倍。这种改进是满足合成降胆固醇药物阿托伐他汀(立普妥)所涉及的商业相关生物催化过程的实际设计标准所必需的,并且是通过具有至少35个突变的变体获得的。